Product Description

NOBIVAC® Canine 1-DAPPv CV is shown to be effective for vaccination of healthy dogs 6 weeks of age or older against canine distemper virus, canine adenovirus type 1 (hepatitis), canine adenovirus type 2 (respiratory disease), canine parainfluenza virus, canine parvovirus and canine coronavirus.
-Recommended for use in healthy dogs 6 weeks of age or older.
-Proven effective against all known strains of canine parvovirus (CPV), including CPV-2c1-®3
-Contains CPV-2b, one of the most prevalent field strains of parvovirus
-High antigenic mass (titer), low passage parvovirus vaccine
-Overrides maternal antibodies in young puppies1
-Proven effective against 2 types of adenovirus that cause hepatitis and respiratory disease in dogs
-Proven effective against commonly spread canine viruses, coronavirus, distemper, adenovirus types 1 and 2, parainfluenza and parvovirus, in 1 formula

WARNINGS:
• Contains gentamicin as a preservative.
• Vaccinate only healthy, non-parasitized dogs.
• Do not vaccinate pregnant bitches.
• The use of a biological product may produce anaphylaxis and/or other inflammatory immune-mediated hypersensitivity reactions. Antidote: Epinephrine, corticosteroids, and antihistamines may all be indicated depending on the nature and severity of the reaction.
• The age at which maternal antibody for canine parvovirus no longer interferes with the development of active immunity varies according to the bitch’s titer and quantity of colostral antibodies absorbed by the puppy.